or Try an Advanced Search...

    Technical Analysis for MDGL - Madrigal Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    B 279.31 -0.30% -0.85
    MDGL closed down 0.3 percent on Monday, July 1, 2024, on 57 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical MDGL trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    MACD Bearish Signal Line Cross Bearish -0.30%
    Three Weeks Tight Range Contraction -0.30%
    Inside Day Range Contraction -0.30%
    Stochastic Sell Signal Bearish -2.22%
    Wide Bands Range Expansion -2.22%
    Overbought Stochastic Strength -2.22%
    Wide Bands Range Expansion 1.43%
    Overbought Stochastic Strength 1.43%
    Older End-of-Day Signals for MDGL ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    10 DMA Resistance about 8 hours ago
    Fell Below 10 DMA about 8 hours ago
    10 DMA Support about 11 hours ago
    Fell Below Previous Day's Low about 11 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    MDGL Chart by TradingView
    Basic chart:

    Profile

    Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medication Lipid Endocrine System Metabolic Disease Cholesterol Thyroid Hypercholesterolemia Dyslipidemia Glands Triglyceride Cardiovascular And Metabolic Diseases Hyperlipidemia Vascular And Metabolic Diseases

    Is MDGL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 30 Is Madrigal Pharmaceuticals a Millionaire Maker?
    Jun 16 Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
    Jun 15 Where Will Madrigal Pharmaceuticals Be in 3 Years?
    Jun 12 Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
    Jun 12 Madrigal Pharmaceuticals: The GLP-1 Threat May Be Overcooked
    Jun 11 Wolfe starts Madrigal at outperform, cites Rezdiffra launch
    Jun 10 Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
    Jun 9 Madrigal May Not Be Able To Shrug GLP-1 Drugs For Long
    Jun 6 Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
    Jun 5 What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
    See more MDGL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 299.98
    52 Week Low 119.7604
    Average Volume 512,463
    200-Day Moving Average 212.90
    50-Day Moving Average 238.13
    20-Day Moving Average 269.11
    10-Day Moving Average 278.35
    Average True Range 13.10
    RSI (14) 60.16
    ADX 20.02
    +DI 30.62
    -DI 21.68
    Chandelier Exit (Long, 3 ATRs) 256.19
    Chandelier Exit (Short, 3 ATRs) 247.91
    Upper Bollinger Bands 303.37
    Lower Bollinger Band 234.86
    Percent B (%b) 0.65
    BandWidth 25.46
    MACD Line 12.22
    MACD Signal Line 12.78
    MACD Histogram -0.5549
    Fundamentals Value
    Market Cap 5.51 Billion
    Num Shares 19.7 Million
    EPS -19.24
    Price-to-Earnings (P/E) Ratio -14.52
    Price-to-Sales 0.00
    Price-to-Book 168.57
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 287.56
    Resistance 3 (R3) 287.66 285.02 286.19
    Resistance 2 (R2) 285.02 282.92 284.97 285.73
    Resistance 1 (R1) 282.16 281.62 283.59 282.06 285.27
    Pivot Point 279.52 279.52 280.23 279.47 279.52
    Support 1 (S1) 276.66 277.42 278.09 276.56 273.35
    Support 2 (S2) 274.02 276.12 273.97 272.89
    Support 3 (S3) 271.16 274.02 272.44
    Support 4 (S4) 271.06